3230 WPI (Meloxicam 7.5 mg)
Pill imprint 3230 WPI has been identified as Meloxicam 7.5 mg.
Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; tendonitis; inflammatory conditions (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Meloxicam 7.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 3230 WPI (Meloxicam 7.5 mg)
- 7.5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|55289-0376||PDRX Pharmaceuticals Inc (repackager)|
|10544-0320||Blenheim Pharmacal Inc (repackager)|
|66336-0099||Dispensing Solutions Inc. (repackager)|
|18837-0239||Innoviant Pharmacy Inc (repackager)|
Note: Inactive ingredients may vary.
Meloxicam is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...